Search

Search Constraints

You searched for: Author/Creator Luijtens, Kristel

Search Results

2. Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population. Issue 1 (December 2015)